Background Extensive endoscopic resections for the treatment of early oesophageal
neoplasia can result in fibro‐inflammatory strictures that require repeated interventions …

Objective: Patient-reported outcome (PRO) measures are commonly used to capture patient
experience with dysphagia and to evaluate treatment effectiveness. Inappropriate …

Background and Aims The prevention of esophageal strictures following circumferential
mucosal resection remains a major clinical challenge. Human amniotic membrane (AM) is …

Introduction Circumferential endoscopic submucosal dissection (ESD) allows to treat large
esophageal superficial neoplasms, however with a high occurrence of severe esophageal …

Circumferential endoscopic resection (ER) of the esophageal mucosa could find its place in
the treatment of dysplastic Barrett's esophagus or extensive squamous cell neoplasia …

Gastrointestinal (GI) strictures are difficult to treat in a variety of disease processes.
Currently, there are no Food and Drug Administration (FDA) approved drugs for fibrosis in …

The development of techniques for endoscopic resection has provided new strategies for
radical conservative treatment of superficial esophageal neoplasms, even those that are …

Esophageal stricture formation after extensive endoscopic resection remains a major
limitation of endoscopic therapy for early esophageal neoplasia. This study assessed a …

Background Endoscopic eradication therapy for dysplastic Barrett's esophagus (BE)
comprises resection and mucosal ablation techniques. Over the years, these techniques …

Background and study aims Esophageal stricture is the most frequent adverse event after
endoscopic resection for early esophageal neoplasia. Currently available treatments for the …